Cardiac Arrest is caused by a heart arrhythmia which is when the electrical signals inside the heart suddenly become erratic. When all of the electrical signals go into total chaos, the heart suddenly stops beating, usually resulting in death. Cardiac arrest should be treated with CPR immediately to support the blood circulation. Once the CPR creates a shockable rhythm, a defibrillator is used to shock the patient’s heart so that it can reorganize itself and resume a regular heartbeat. People with underlying heart conditions, previous heart attack, and heart disease are more susceptible to cardiac arrest as well as users of illicit drugs. Cardiac should not be confused with heart attack.
Cardiac Arrest Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Cardiac Arrest below!
For more information on how to use Laverne, please read the How to Guide.
We have 1808 products for the study of Cardiac Arrest that can be applied to Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.
Cardiac Arrest is also known as Arrest Cardiac, Arrest, Cardiac, Arrest, Heart, Asystole, Asystoles.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.